Ubs Group Ag Tonix Pharmaceuticals Holding Corp. Transaction History

Ubs Group Ag

  • $400 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
SELL
$0.46 - $1.3 $19,197 - $54,252
-41,733 Reduced 61.8%
25,795 $15,000
Q4 2022

Feb 08, 2023
BUY
$0.29 - $0.57 $19,479 - $38,288
67,172 Added 18868.54%
67,528 $26,000
Q3 2022

Nov 10, 2022
SELL
$0.53 - $1.9 $12,566 - $45,049
-23,710 Reduced 98.52%
356 $0
Q2 2022

Aug 10, 2022
BUY
$1.58 - $7.36 $38,024 - $177,125
24,066 New
24,066 $38,000

About Tonix Pharmaceuticals Holding Corp.

TNXP Quotes by TradingView
  • Ticker TNXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,752,700
  • Market Cap $7.25M
  • Description
  • Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candid...
More about TNXP
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email